Inventor · disambiguated record
Jonathan Hsu
Also filed as: HSU JONATHAN · HSU JONATHAN YEE-TING
8 granted patents·13 pending applications·20 citations·filing 2016–2025
83Inventor score
Files withMARENGO THERAPEUTICS INC17ABLYNX NV1BROAD INST INC1MASSACHUSETTS GEN HOSPITAL1MASSACHUSETTS INST TECHNOLOGY1
Top patents by PatentIndex Score
21 records- 0195US11965025B2Method of treating solid cancers with bispecific interleukin-anti-TCRß moleculesMARENGO THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·7 cites·26 claims
- 0293US11845797B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2019·Granted Dec 19, 2023·7 cites·34 claims
- 0392US12351632B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Granted Jul 8, 2025·1 cites·33 claims
- 0491US12486326B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·1 cites·10 claims
- 0591US12286477B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Granted Apr 29, 2025·1 cites·29 claims
- 0686US2024301060A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0782US2025340640A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0878US2025215085A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0977US2022064297A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1073US11248055B2Polypeptides inhibiting CD40LABLYNX NV·Filed 2016·Granted Feb 15, 2022·2 cites·13 claims
- 1171US12406749B2Systems and methods for predicting repair outcomes in genetic engineeringBROAD INST INC·Filed 2018·Granted Sep 2, 2025·1 cites·13 claims
- 1270US2023227552A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1366US2024409636A1Multifunctional molecules binding to tcr and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1463US2025333500A1Multifunctional molecules that bind to t cell related cancer cells and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1561US12358982B2Multifunctional molecules that bind to T cell related cancer cells and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Granted Jul 15, 2025·0 cites·23 claims
- 1659US2021380692A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1757US2025099579A1Multispecific molecules binding to tcr and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1854US2023245716A1Systems and Methods for Stable and Heritable Alteration by Precision Editing (SHAPE)MASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 1952US2021380670A1Multifunctional molecules that bind to calreticulin and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2051US2021380691A1Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disordersMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2145US2020040329A1Systems and methods for predicting repair outcomes in genetic engineeringMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Hsu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →